Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration.
<h4>Background</h4>Meta-analyses of antidepressant medications have reported only modest benefits over placebo treatment, and when unpublished trial data are included, the benefit falls below accepted criteria for clinical significance. Yet, the efficacy of the antidepressants may also d...
Guardado en:
Autores principales: | Irving Kirsch, Brett J Deacon, Tania B Huedo-Medina, Alan Scoboria, Thomas J Moore, Blair T Johnson |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2008
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2c20cf1281c54e7bb3bcbb38e195c644 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Reporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentation.
por: Kristin Rising, et al.
Publicado: (2008) -
Augmentation with antidepressants in schizophrenia treatment: benefit or risk
por: Mao YM, et al.
Publicado: (2015) -
Additive Antidepressant Effects of Combined Administration of Ecitalopram and Caloric Restriction in LPS-Induced Neonatal Model of Depression in Rats
por: Haritov E., et al.
Publicado: (2020) -
Submitting to God
por: Sara Ababneh
Publicado: (2011) -
Neuroimmune endocrine effects of antidepressants
por: Antonioli M, et al.
Publicado: (2012)